(GEM) Goldman Sachs ActiveBeta - NYSE
ETF Category: Diversified Emerging Mkts | Exchange: NYSE (USA) | Market Cap: 1.644m USD | Total Return: 46.5% in 12m
Avg Turnover: 4.50M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
The Goldman Sachs ActiveBeta® Emerging Markets Equity ETF (GEM) targets long-term capital growth by tracking a proprietary index of emerging market equities. The fund maintains a mandate to invest at least 80% of its assets in the components of its underlying index or corresponding depositary receipts. This strategy provides diversified exposure to developing economies, which often exhibit higher GDP growth rates compared to mature markets but carry increased geopolitical and currency risk.
The fund utilizes a multi-factor selection process, typically focusing on attributes such as value, momentum, quality, and low volatility. Emerging market ETFs frequently include heavy weightings in the technology, financial, and consumer discretionary sectors of nations like China, India, and Brazil. Investors looking for deeper fundamental insights into these holdings may find ValueRay a useful tool for further analysis.
Launched in 2015, GEM is classified within the Diversified Emerging Markets category and currently manages approximately $1.67 billion in assets. By utilizing depositary receipts, the fund gains efficient access to foreign listings that might otherwise be restricted or difficult for domestic investors to trade directly.
- Emerging market central bank pivot cycles influence regional equity valuations
- US dollar strength creates performance headwinds for non-USD denominated assets
- China economic recovery and stimulus measures drive broader index returns
- Smart beta factor weighting reduces volatility relative to market-cap benchmarks
As of June 15, 2026, the stock is trading at USD 51.53 with a total of 90,342 shares traded.
Over the past week, the price has changed by +4.99%,
over one month by +1.16%,
over three months by +19.50% and
over the past year by +46.48%.
Goldman Sachs ActiveBeta has no consensus analysts rating.